24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting

BACKGROUND: To evaluate the clinical effectiveness and analyze the outcomes of a treat-and-extend (T&E) treatment regimen with ranibizumab for wet age-related macular degeneration (ARMD) in real life clinical settings over the first 2 years (24 months) of treatment. METHODS: Retrospective analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Vardarinos, Athanasios, Gupta, Nitin, Janjua, Raazia, Iron, Abigail, Empeslidis, Theo, Tsaousis, Konstantinos T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408417/
https://www.ncbi.nlm.nih.gov/pubmed/28449645
http://dx.doi.org/10.1186/s12886-017-0451-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408417/
https://www.ncbi.nlm.nih.gov/pubmed/28449645
http://dx.doi.org/10.1186/s12886-017-0451-1

Ejemplares similares